AhnSJRyooNKWooSJ.Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014;4:134-141.
4.
WilkinsonCPWelchRB.Intraocular Toxocara. Am J Ophthalmol. 1971;71:921-930. doi:10.1016/0002-9394(71)90267-4
5.
Centers for Disease Control and Prevention (CDC). Ocular toxocariasis—United States, 2009-2010. MMWR Morb Mortal Wkly Rep. 2011;60:734-736.
6.
SmithHHollandCTaylorMMagnavalJFSchantzPMaizelsR.How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182-188.
7.
WonKYKruszon-MoranDSchantzPMJonesJL.National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Am J Trop Med Hyg. 2008;79:552-557.
8.
WorleyGGreenJAFrothinghamTEet al. Toxocara canis infection: clinical and epidemiological associations with seropositivity in kindergarten children. J Infect Dis. 1984;149:591-597.
9.
MaetzHMKleinsteinRNFedericoDWayneJ.Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 1987;156:414.
10.
StewartJMCubillanLDPCunninghamETJr.Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005-1013.
11.
WoodhallDStarrMCMontgomerySPet al. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012;119:1211-1217.
12.
Barisani-AsenbauerTMacaSMHauffWet al. Treatment of ocular toxocariasis with albendazole. J Ocul Pharmacol Ther. 2001;17:287-294.
13.
AhnSJWooSJJinYet al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014;8:e2938.
14.
GiuliariGPRamirezGCortezRT.Surgical treatment of ocular toxocariasis: anatomic and functional results in 45 patients. Eur J Ophthalmol. 2010;21:490-494.